Absci (ABSI) Cash & Equivalents (2020 - 2026)

Absci has disclosed Cash & Equivalents across 7 years of filings, most recently posting $8.6 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $8.6 million, down 81.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.6 million (down 81.64% YoY), and the FY2025 annual result was $20.0 million, down 51.41% from the prior year.
• Cash & Equivalents came in at $8.6 million for Q1 2026 at Absci, down from $20.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $226.0 million in Q1 2022 to a low of $8.6 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $42.9 million (2024), against an average of $61.3 million.
• Across the five-year window, Cash & Equivalents plunged 94.95% in 2023 and surged 415.65% in 2024, its largest moves.
• Absci's Cash & Equivalents stood at $60.0 million in 2022, then climbed by 20.69% to $72.4 million in 2023, then slumped by 43.05% to $41.2 million in 2024, then slumped by 51.41% to $20.0 million in 2025, then slumped by 56.92% to $8.6 million in 2026.
• The last three Cash & Equivalents figures came in at $8.6 million (Q1 2026), $20.0 million (Q4 2025), and $9.5 million (Q3 2025), per Business Quant data.